Samsung-affiliated hospital in South Korea develops AI robot as surgical assistant, Nikkei reports

The Nikkei reported on October 27, 2026, that a Samsung-affiliated hospital in South Korea developed an AI robot as an “assistant” in surgery. The headline does not provide details about its functions or deployment.

The reported development of an AI robot as a surgical assistant is an example of a medical institution taking part in development. However, the headline does not confirm its functions or clinical use, and more information is needed to assess the scope of its application in medical practice.

The report focuses on the concept of an AI robot supporting surgery as an “assistant” and identifies a Samsung-affiliated hospital as the developer. The headline alone does not show whether the robot handles instruments, provides information or records, or performs another support function. The term “assistant” should not be taken to mean that the robot performs surgery autonomously or is already being used in clinical settings. The hospital’s role as developer may indicate that the work draws on needs in medical practice, but it does not mean the hospital alone is responsible for the device’s design, the AI’s decision-making functions or its operating framework. The headline does not identify development partners or the technology involved, or explain how responsibilities are divided in the operating room. The name of the developer alone is therefore not enough to assess the degree of vertical integration. At this point, the report establishes only that a medical institution was involved in developing a surgical support robot; there is no basis in the headline for inferring that it has been commercialized or introduced clinically. To assess the implications for the industry, it will be important to know which tasks the robot is designed to support and what decisions and operations remain with medical professionals. In surgical support, deployment conditions depend not only on the functions available but also on how the system stops in case of malfunction, how medical professionals can intervene and how effects on patients are evaluated. It is not clear how these mechanisms are designed in this case. Further information is needed on the specific support functions, the stage of development and evaluation, clinical use to date, and the status of approvals and safety assessments. Until those details are available, development announcements should be distinguished from practical use in medical settings.